These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28450191)

  • 1. Targeting neuronal nitric oxide synthase by a cell penetrating peptide Tat-LK15/siRNA bioconjugate.
    Peng J; Rao Y; Yang X; Jia J; Wu Y; Lu J; Tao Y; Tu W
    Neurosci Lett; 2017 May; 650():153-160. PubMed ID: 28450191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivery of therapeutic shRNA and siRNA by Tat fusion peptide targeting BCR-ABL fusion gene in Chronic Myeloid Leukemia cells.
    Arthanari Y; Pluen A; Rajendran R; Aojula H; Demonacos C
    J Control Release; 2010 Aug; 145(3):272-80. PubMed ID: 20403398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved Tat-mediated plasmid DNA transfer by fusion to LK15 peptide.
    Saleh AF; Aojula H; Arthanari Y; Offerman S; Alkotaji M; Pluen A
    J Control Release; 2010 Apr; 143(2):233-42. PubMed ID: 20060860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delivery of siRNA to the brain using a combination of nose-to-brain delivery and cell-penetrating peptide-modified nano-micelles.
    Kanazawa T; Akiyama F; Kakizaki S; Takashima Y; Seta Y
    Biomaterials; 2013 Dec; 34(36):9220-6. PubMed ID: 23992922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel cell-penetrating peptide TAT-A1 delivers siRNA into tumor cells selectively.
    Fang B; Jiang L; Zhang M; Ren FZ
    Biochimie; 2013 Feb; 95(2):251-7. PubMed ID: 23009929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell penetrating peptide conjugated bioreducible polymer for siRNA delivery.
    Nam HY; Kim J; Kim S; Yockman JW; Kim SW; Bull DA
    Biomaterials; 2011 Aug; 32(22):5213-22. PubMed ID: 21501867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinase-1 induces cleavage of exogenous alphaB-crystallin transduced by a cell-penetrating peptide.
    Yang SW; Lee SM; Choi EY; Lee KH; Kim SH; Shin MJ; Han YS; Kang SM; Chung JH
    J Cell Biochem; 2011 Sep; 112(9):2454-62. PubMed ID: 21538481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of elastin-like polypeptide for targeted specific gene delivery in vivo.
    Yi A; Sim D; Lee YJ; Sarangthem V; Park RW
    J Nanobiotechnology; 2020 Jan; 18(1):15. PubMed ID: 31952530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative characterization and cytotoxicity study of TAT-peptide as potential vectors for siRNA and Dicer-substrate siRNA.
    Katas H; Abdul Ghafoor Raja M; Ee LC
    Drug Dev Ind Pharm; 2014 Nov; 40(11):1443-50. PubMed ID: 23962166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient siRNA Delivery Using Novel Cell-Penetrating Peptide-siRNA Conjugate-Loaded Nanobubbles and Ultrasound.
    Xie X; Lin W; Li M; Yang Y; Deng J; Liu H; Chen Y; Fu X; Liu H; Yang Y
    Ultrasound Med Biol; 2016 Jun; 42(6):1362-74. PubMed ID: 27012462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-penetrating peptide-conjugated lipid nanoparticles for siRNA delivery.
    Asai T; Tsuzuku T; Takahashi S; Okamoto A; Dewa T; Nango M; Hyodo K; Ishihara H; Kikuchi H; Oku N
    Biochem Biophys Res Commun; 2014 Feb; 444(4):599-604. PubMed ID: 24486551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolongation of life in rats with malignant glioma by intranasal siRNA/drug codelivery to the brain with cell-penetrating peptide-modified micelles.
    Kanazawa T; Morisaki K; Suzuki S; Takashima Y
    Mol Pharm; 2014 May; 11(5):1471-8. PubMed ID: 24708261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of an efficient transdermal delivery system of small interfering RNA using functional peptides, Tat and AT-1002.
    Uchida T; Kanazawa T; Takashima Y; Okada H
    Chem Pharm Bull (Tokyo); 2011; 59(2):196-201. PubMed ID: 21297299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Efficiency of Tat Cell Penetrating Peptide for Intracellular Uptake of HIV-1 Nef Expressed in E. coli and Mammalian Cell.
    Kadkhodayan S; Bolhassani A; Sadat SM; Irani S; Fotouhi F
    Curr Drug Deliv; 2017; 14(4):536-542. PubMed ID: 27719633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of tumor growth by systemic delivery of anti-VEGF siRNA with cell-penetrating peptide-modified MPEG-PCL nanomicelles.
    Kanazawa T; Sugawara K; Tanaka K; Horiuchi S; Takashima Y; Okada H
    Eur J Pharm Biopharm; 2012 Aug; 81(3):470-7. PubMed ID: 22579732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium condensed cell penetrating peptide complexes offer highly efficient, low toxicity gene silencing.
    Baoum A; Ovcharenko D; Berkland C
    Int J Pharm; 2012 May; 427(1):134-42. PubMed ID: 21856394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA silencing targeting PIN (protein inhibitor of neuronal nitric oxide synthase) attenuates the development of hypertension in young spontaneously hypertensive rats.
    Wang SC; Lin KM; Chien SJ; Huang LT; Hsu CN; Tain YL
    J Am Soc Hypertens; 2014 Jan; 8(1):5-13. PubMed ID: 24035314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and evaluation of a stearylated multicomponent peptide-siRNA nanocomplex for efficient cellular siRNA delivery.
    Wan Y; Moyle PM; Gn PZ; Toth I
    Nanomedicine (Lond); 2017 Feb; 12(4):281-293. PubMed ID: 28093948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly efficient delivery of siRNA to a heart transplant model by a novel cell penetrating peptide-dsRNA binding domain.
    Li H; Zheng X; Koren V; Vashist YK; Tsui TY
    Int J Pharm; 2014 Jul; 469(1):206-13. PubMed ID: 24768403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Six-cell penetrating peptide-based fusion proteins for siRNA delivery.
    Li H; Tsui T
    Drug Deliv; 2015 May; 22(3):436-43. PubMed ID: 24491156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.